![Yue Hsin Lin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Yue Hsin Lin
Founder at
LIN BIOSCIENCE, INC.
Net worth: 54 M $ as of 2026-06-29
Profile
Yue Hsin Lin is the founder of Lin BioScience, Inc. (2016, Chairman) and Belite Bio, Inc. (2018, Chairman & Chief Executive Officer).
Current jobs include Chief Executive Officer & Director at RBP4 Pty Ltd. (2021), Chairman, President & Chief Executive Officer at Belite Bio Holdings Corp.
(2021), Director at Belite Bio (HK) Ltd. (2021), and President at Belite Bio LLC (2021).
Former jobs include Senior Director-Medical at OBI Pharma, Inc. (2010-2014), Medical Director & General Manager at Aslan Pharmaceuticals Ltd., and President & Chief Operating Officer at CVie Therapeutics Ltd. (2014-2016).
Education includes an MBA from The Trustees of Columbia University in The City of New York, an undergraduate degree from the University of Pennsylvania, an MBA from The University of Hong Kong, a doctorate from The University of Sydney, and an MBA from London Business School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
BELITE BIO, INC. 1.42% | 2026-04-20 | 353,883 ( 1.42% ) | 54 M $ | 2026-06-29 |
Yue Hsin Lin active positions
| Companies | Position | Start |
|---|---|---|
| LIN BIOSCIENCE, INC. | Founder | 2016-05-11 |
| BELITE BIO, INC | Chief Executive Officer | 2018-03-26 |
Belite Bio LLC
 Belite Bio LLC Pharmaceuticals: MajorHealth Technology Operates clinical stage biopharmaceutical drug development company | President | 2021-09-30 |
RBP4 Pty Ltd. | Chief Executive Officer | 2021-03-31 |
Belite Bio Holdings Corp.
 Belite Bio Holdings Corp. Aerospace & DefenseElectronic Technology Part of Lin BioScience, Inc., Belite Bio Holdings Corp. is a clinical stage biopharmaceutical drug development company that specializes in the development of novel therapeutics for retinal degenerative eye diseases with significant unmet medical needs. The company is based in San Diego, CA. Yue Hsin Lin has been the CEO of the company since 2016. | Chief Executive Officer | 2017-11-30 |
Belite Bio (HK) Ltd. | Director/Board Member | 2021-05-31 |
Former positions of Yue Hsin Lin
| Companies | Position | End |
|---|---|---|
CVie Therapeutics Ltd.
 CVie Therapeutics Ltd. BiotechnologyHealth Technology Develops and researched drugs | President | 2015-12-31 |
| OBI PHARMA, INC. | Chief Tech/Sci/R&D Officer | 2013-12-31 |
| ASLAN PHARMACEUTICALS LIMITED | Chief Tech/Sci/R&D Officer | - |
Training of Yue Hsin Lin
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
12
1st degree connections
14
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 14 |
|---|---|
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Hong Kong
 University of Hong Kong Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Sydney
 The University of Sydney Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
London Business School
 London Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OBI Pharma, Inc.
 OBI Pharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures anti-infective and immunotherapy drugs | Health Technology |
Aslan Pharmaceuticals Ltd.
 Aslan Pharmaceuticals Ltd. BiotechnologyHealth Technology Operates as biotechnology company which develops immuno-oncology agents and targeted therapies | Health Technology |
Lin BioScience, Inc.
 Lin BioScience, Inc. BiotechnologyHealth Technology Engages in discovering and development of drugs for cancer treatment and eye diseases | Health Technology |
CVie Therapeutics Ltd.
CVie Therapeutics Ltd. BiotechnologyHealth Technology Develops and researched drugs | Health Technology |
Belite Bio LLC
Belite Bio LLC Pharmaceuticals: MajorHealth Technology Operates clinical stage biopharmaceutical drug development company | Health Technology |
Belite Bio, Inc.
 Belite Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical stage biopharmaceutical drug development company | Health Technology |
RBP4 Pty Ltd. | |
Belite Bio Holdings Corp.
Belite Bio Holdings Corp. Aerospace & DefenseElectronic Technology Part of Lin BioScience, Inc., Belite Bio Holdings Corp. is a clinical stage biopharmaceutical drug development company that specializes in the development of novel therapeutics for retinal degenerative eye diseases with significant unmet medical needs. The company is based in San Diego, CA. Yue Hsin Lin has been the CEO of the company since 2016. | Electronic Technology |
Belite Bio (HK) Ltd. |
- Stock Market
- Insiders
- Yue Hsin Lin
